Has Hunter Hall International lost its mojo?

Or could this fund manager be heading for a turn around?

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

With most fund managers putting in strong investment performances over the past year, the black sheep of the family is most definitely Hunter Hall International (ASX: HHL).

Hunter Hall manages one listed fund, Hunter Hall Global Value (ASX: HHV), and five unlisted funds, with the flagship being the Value Growth Fund. The Value Growth Fund (unlisted) has beaten the All Ords accumulation index comfortably over 15 and 10 years, however it's a different story over the last five-, three- and one-year periods. On a comparative basis, results have been lacklustre. And the HHL share price has been dismal, falling over 50% in the past year alone. In short, Hunter Hall International appears to be heading for irrelevance and possibly redundancy. What are they doing about it? Let's have a look.

Keep seeking value, not fashion

Hunter Hall is not a momentum or market orientated player; it is a focused, international value investor, and will usually hold investments over a number of years. This has led it into companies unfamiliar to the typical retail investor such as Sberbank (Russia's dominant bank), Samchully (South Korea's premier energy distributor) and Danieli (an Italian parts and equipment supplier to the metals industry). These three are well established companies with a long history of profitability and quality balance sheets.

Companies such as these are available at significantly lower comparative prices when compared to domestic equivalents. For example, Sberbank's price earnings ratio is 6.3 and its history goes back to 1841 — not exactly a fly-by-nighter. Some better known names held in the international funds are Apple, Expedia and Sumitomo Electric.

There have been a few good performers across the funds – including Sirtex (ASX: SRX), M2 Telecommunications (ASX: MTU) and Resmed (ASX: RMD) (all Australian based). However the occasional birdsong doesn't make a spring and a challenging international economic environment (especially in Europe) over the past three years has led to consistent fund outflows with investors going elsewhere. As far as many financial advisers are concerned, Hunter Hall has left the building.

Developing products

Hunter Hall has not done much in the way of adding depth to its offerings over its 19-year listed history. A couple of attempts have quietly been closed due to lack of interest. A very recent offering (July 16, 2013) is a wholesale fund with a management fee of 1%pa and no performance fees. The difficulty with Hunter Hall's positioning is the present lack of investor demand for international shares (midcaps especially). However, with many favoured domestic shares (banks, supermarkets etc) looking fully valued, this situation is likely to change over the medium term.

Strengthening capabilities and reach

David Deverall (previously Perpetual's CEO) was appointed as managing director of Hunter Hall in July 2012. A number of administrative and marketing changes have been implemented. Further structural moves are in progress and the benefits of these should be apparent by 2014.

Foolish takeaway

HHL has no debt, solid cashflow from base fees, and a market capitalisation of $50 million. Funds management companies have extreme leverage to fund flows, sentiment and the quality of stock selections. On the positive side, both investment performance and fund flows have improved in recent months, partly due to the weakening Aussie dollar. Looking to 2014, a rough but conservative estimate would be earnings of 20c per share and a partly franked dividend of 17c per share. At $1.80, this places HHL on a PE of 9, and a dividend yield of 9.4% — not unattractive. It's near the top of this investor's watchlist.

Interested in our #1 dividend-paying stock? Discover The Motley Fool's favourite income idea for 2013-2014 in our brand-new, FREE research report, including a full investment analysis! Simply click here for your FREE copy of "The Motley Fool's Top Dividend Stock for 2013-2014."

More reading


Motley Fool contributor Peter Andersen does not own shares in any company mentioned in this article. 

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »